Ollin Biosciences, Inc.
Ollin Biosciences, Inc.
Explore linked clinical trials.4 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase 3 Study of Intravitreal OLN324 in Adults With Diabetic Macular Edema (DME) (OLN324-CP-03) | Diabetes Complications, cardiovascular disorder, diabetes mellitus, diabetic peripheral angiopathy, diabetic retinopathy, endocrine system disorder, eye disorder, retinal disorder, vascular disorder | Not yet recruiting | Phase 3 | 2026-09-25 | NCT07842016 | |
| Phase 3 Study of Intravitreal OLN324 in Adults With Diabetic Macular Edema (DME) (OLN324-CP-02) | Diabetes Complications, cardiovascular disorder, diabetes mellitus, diabetic peripheral angiopathy, diabetic retinopathy, endocrine system disorder, eye disorder, retinal disorder, vascular disorder | Not yet recruiting | Phase 3 | 2026-09-25 | NCT07841899 | |
| Phase 3 Study of Intravitreal OLN324 in Adults With Neovascular (Wet) Age-related Macular Degeneration (nAMD) (OLN324-CP-04) | eye disorder, macular degeneration, retinal degeneration, retinal disorder, wet macular degeneration | Not yet recruiting | Phase 3 | 2026-09-11 | NCT07816315 | |
| Phase 3 Study of Intravitreal OLN324 in Adults With Neovascular (Wet) Age-related Macular Degeneration (nAMD) (OLN324-CP-05) | eye disorder, macular degeneration, retinal degeneration, retinal disorder | Not yet recruiting | Phase 3 | 2026-09-11 | NCT07816289 |